Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Xu

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 7, 2019
[Clinical implication of minimal residue disease monitoring by WT1 gene detection and flow cytometry in myelodysplastic syndrome with allogeneic stem cell transplantation]X S Zhao, X D Mo, Y Hong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2024
[Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation]J Zhang, R Ma, X Y Luo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2024
[Causes and characteristics of pre-engraftment mortality after allogeneic hematopoietic stem cell transplantation]J Liu, M Lyu, Y Y Zhang, et al.
Bone Marrow Transplantation|May 29, 2012
A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemiaL P Xu, K Y Liu, D H Liu, et al.
Bone Marrow Transplantation|January 11, 2012
Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCTX-D Mo, L-P Xu, D-H Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation]X X Liu, J Kong, S A Pan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2020
[Hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities: report of three cases and literature review]H X Fu, Y Q Gu, Y Y Lai, et al.
Zhonghua Nei Ke Za Zhi|November 7, 2023
[Prognostic analysis of patients with acute leukemia and central nervous system involvement undergoing allogeneic hematopoietic stem cell transplantation]J Liu, R Ma, Y He, et al.
Zhonghua Nei Ke Za Zhi|February 5, 2023
[Clinical characteristics of patients with human adenovirus infection undergoing allogeneic hematopoietic stem cell transplantation]T T Han, Y Hong, F F Wei, et al.
Zhonghua Nei Ke Za Zhi|October 7, 2024
[Clinical outcomes of allogeneic hematopoietic stem cell transplantation from matched sibling donor for myelofibrosis]R Ma, B R Tang, T T Han, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 7, 2019
[Clinical implication of minimal residue disease monitoring by WT1 gene detection and flow cytometry in myelodysplastic syndrome with allogeneic stem cell transplantation]X S Zhao, X D Mo, Y Hong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2024
[Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation]J Zhang, R Ma, X Y Luo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 12, 2024
[Causes and characteristics of pre-engraftment mortality after allogeneic hematopoietic stem cell transplantation]J Liu, M Lyu, Y Y Zhang, et al.
Bone Marrow Transplantation|May 29, 2012
A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemiaL P Xu, K Y Liu, D H Liu, et al.
Bone Marrow Transplantation|January 11, 2012
Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCTX-D Mo, L-P Xu, D-H Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation]X X Liu, J Kong, S A Pan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2020
[Hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities: report of three cases and literature review]H X Fu, Y Q Gu, Y Y Lai, et al.
Zhonghua Nei Ke Za Zhi|November 7, 2023
[Prognostic analysis of patients with acute leukemia and central nervous system involvement undergoing allogeneic hematopoietic stem cell transplantation]J Liu, R Ma, Y He, et al.
Zhonghua Nei Ke Za Zhi|February 5, 2023
[Clinical characteristics of patients with human adenovirus infection undergoing allogeneic hematopoietic stem cell transplantation]T T Han, Y Hong, F F Wei, et al.
Zhonghua Nei Ke Za Zhi|October 7, 2024
[Clinical outcomes of allogeneic hematopoietic stem cell transplantation from matched sibling donor for myelofibrosis]R Ma, B R Tang, T T Han, et al.
Pageof 16